Clinical diagnostic criteria of efficiency for combined etiopathogenetic therapy in patients with chronic Epstein–Barr virus infection
Treatment of chronic viral infections accompanied by permanent virus persistence in the target epitopes of the oral cavity, skin, urogenital tract is complicated by virtual lack of available drugs exerting combined systemic virulicidal and immunomodulatory effects. Here we demonstrate clinical and i...
Guardado en:
Autores principales: | V. A. Zurochka, O. I. Zabkov, M. A. Dobrynina, V. F. Gritsenko, E. V. Davydova, A. V. Chukichev, N. A. Zabokritskii, A. P. Sarapultsev, A. V. Zurochka |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Sankt-Peterburg : NIIÈM imeni Pastera
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f8ae2a011984f6db0e2e33dd0e78757 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
THE MODERN CONCEPTIONS ABOUT IMMUNOPATHOGENESIS OF INFECTION CAUSED BY THE EPSTEIN–BARR VIRUS
por: T. V. Goreiko, et al.
Publicado: (2014) -
Falla hepática fulminante por virus Epstein Barr: Rol de los corticoides. Caso clínico
por: VIVIANI G,PAULA, et al.
Publicado: (2013) -
Convulsiones y paro cardiaco: forma inhabitual de presentación de miocarditis asociada a virus de Epstein Barr
por: Mericq G,Verónica, et al.
Publicado: (1993) -
CLINICAL-IMMUNOLOGY EFFICIENCY OF CONSERVATIVE TREATMENT OF PATIENTS WITH CHRONIC TONSILLITIS ASSOCIATED WITH EPSTEIN - BARR VIRUS INFECTION
por: A. S. Krasnitskaja, et al.
Publicado: (2012) -
Latent Membrane Protein 1 Is a Novel Determinant of Epstein-Barr Virus Genome Persistence and Reactivation
por: Elizabeth A. Caves, et al.
Publicado: (2017)